ATHOS-3 Trial Summary:
A total of 321 patients with vasodilatory shock on high dose catecholamines were randomized to angiotensin II or placebo. Within 3 hours, ~70% of in the angiotensin II group showed significant improvement in their mean arterial pressure as compared with 23.4% patients in
ATHOS-3 Trial 2017, Angiotensin II for the Treatment of Vasodilatory Shock, NEJM
Want to read more posts?